“The impact that we have had that we have shown today is a hugely important potential breakthrough in the treatment of the condition called Lennox-Gastaut syndrome,” Gover said. Lennox-Gastaut syndrome is a rare and severe form of epilepsy that begins in childhood.
GW Pharma, based in the England, grows its own cannabis plants for research.
“The positive outcome in this second trial of Epidiolex in patients with Lennox-Gastaut syndrome demonstrates the effectiveness of this product in this particularly difficult to treat, childhood-onset epilepsy,” said Dr. Orrin Devinsky, of New York University Langone Medical Center’s Comprehensive Epilepsy Center, and principal investigator in the trial.
The results of the trial showed “high statistical significance,” which means the treatment was extremely effective in helping these patients.
The trial supports two earlier late-stage clinical studies, one in children with Lennox-Gastaut and one in patients with Dravet syndrome, another form of epilepsy—both of which demonstrated equally promising results. There are currently no FDA-approved treatments for Dravet syndrome.
“The unusual feature of this program is that we are developing the drug for two different types of epilepsy in parallel, and we have agreement from FDA to make one submission for the drug in two different indications,” Gover told the Telegraph. “That is unusual.”
This latest news puts GW Pharmaceuticals on track to file a new drug application with the FDA in the first half of 2017.
As to be expected, GW’s stock soared more than 17 percent after the announcement.
Florida Farmers May Soon Be Allowed to Grow Hemp
Female Icons: Modern Women in Weed Recreate History
DEA, Customs and Border Patrol Seek Contractors to Incinerate Narcotics
Virginia General Assembly Strikes Down Cannabis Law Reform Bills
Missouri Police Raid Hospital Room of Stage 4 Cancer Patient Using Cannabis
Oklahoma House Passes Medical Cannabis Protection Bill
Colorado Researchers Seeking Volunteers to Get High and Drive
Ohio Highway Patrol Confiscates 55 Gallons of CBD Oil During Traffic Stop
Culture4 days ago
What It Was Like Doing Mushrooms With Grateful Dead’s Bob Weir
News5 days ago
Over 800 CVS Stores Will Start Carrying CBD Products
News6 days ago
Pennsylvania Town Decriminalizes Marijuana, Sees Future in Legal Pot
Sponsored5 days ago
Three Reasons Why Live Resin Represents the Future of Cannabis Products
Health6 days ago
Study Finds Correlation of Daily High Potency Cannabis Use and Mental Illness
News6 days ago
National Poll Finds 61 Percent of Americans in Favor of Legalizing Marijuana
News4 days ago
Meet Your New Instagram Crush: 420 Old Fat Lesbians
Sponsored4 days ago
DeltaGate: Richard Nixon’s Sneaky Fight Against Delta-8 THC